CARRECA, Ignazio
CARRECA, Ignazio
Medicina di Precisione in Area Medica, Chirurgica e Critica
1. Uncommon Unresectable Advanced Ulcerative Scirrhous Carcinoma of the Nipple Destroying skin, Chest, Muscles and Ribs. Complete Remission (CR) After Epidoxorubicin (EDOX) + Gemcitabine (GEM) Weekly Administration - A Case Report
2005-01-01 CARRECA I; MARCO BURGIO; SALVATORE RUSSO; DARIO PIAZZA; ANNA CIGNO; LODOVICO BALDUCCI
A phase II study of oxaliplatin (O) and gemcitabine (G) first line chemotherapy in patients with advanced biliary tract cancers
2005-01-01 N GEBBIA; F VERDERAME; R DI LEO; D SANTANGELO; G CICERO; M R VALERIO; C ARCARA; G BADALAMENTI; F FULFARO; CARRECA I
Alla ricerca della sicurezza e della qualità: il modello di miglioramento dell’Oncologia nel Policlinico Universitario di Palermo
2015-01-01 Russo, A; Carreca, I; Seta, C; Procaccianti, P; De Leo, G; Firenze, A; Aprea, L
An all-oral combination regimen of vinorelbine and capecitabine for elderly patients with metastatic breast cancer
2006-01-01 CARRECA I; BRONTE G; BURGIO M; CARRECA A; PIAZZA D; RIZZO S; RUSSO S
Antiangiogenic effects, safety and feasibility of two different capecitabine/Oxaliplatin-based schedules in elderly colorectal cancer patients
2006-01-01 CARRECA I; GIUSEPPE BRONTE; MARCO BURGIO; DARIO PIAZZA; SERGIO RIZZO; SALVATORE RUSSO; LAURA TARTAGLIA; ANNA CIGNO AND LODOVICO BALDUCCI
Antiangiogenic scheduling of lower dose chemotherapy in elderly patients with advanced colorectal cancer
2006-01-01 CARRECA I; FERNANDA BELLOMO; GIUSEPPE BRONTE; DARIO PIAZZA; SERGIO RIZZO; SALVATORE RUSSO; ANNAPAOLA CARRECA AND LODOVICO BALDUCCI
Cancer chemotherapy in the older cancer patient
2009-01-01 Carreca, I; Balducci, L
Cancer in the older person
2005-01-01 CARRECA, I; BALDUCCI, L; EXTERMANN, M
Capecitabine (XEL) + Oxaliplatin (OX) in elderly people (EP) with Colorectal Cancer (CRC): Comparison of safety (S) and feasibility (F) of two different schedules. Preliminary findings
2005-01-01 CARRECA I; S RIZZO; G BRONTE; M BURGIO; S FIORINO; G MAGGIO; A CIGNO; AP CARRECA; S RUSSO; D PIAZZA
Capecitabine (XEL) and oxaliplatin (OX) in combination with bevacizumab (BEV) in the management of elderly patients with advanced colorectal cancer (ACRC): Preliminary outcomes on safety and efficacy.
2010-01-01 Carreca, i; Bellomo, f; Burgio, l; Carreca, ap; Pernice, g; Piazza, d; Russo, s; Balducci, l
Combined treatment with fulvestrant plus capecitabine in elderly advanced breast cancer (EABC): Three-year evaluation of efficacy and safety
2010-01-01 Carreca, i; Amelio, r; Bellomo, f; Galvano, a; Pernice, g; Piazza, d
Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis.
2007-01-01 CARRECA I; F BELLOMO; G BRONTE; M BURGIO; A CARRECA; D PIAZZA; S RIZZO; S RUSSO; L BALDUCCI
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?
2013-01-01 Amodeo, V; Bazan, V; Fanale, D; Insalaco, L; Caruso, S; Cicero, G; Bronte, G; Rolfo, C; Santini, D; Russo, A
Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect?
2006-01-01 S DARWISH; G BRONTE; A IGNOTO; D PIAZZA; S RIZZO; S RUSSO; CARRECA I
EMATOPOIESI E INVECCHIAMENTO
2006-01-01 BALDUCCI L; CARRECA I; COVA D; LORUSSO V
Founder mutations in BRCA1 and BRCA2 genes
2007-01-01 FERLA, R; CALO', V; CASCIO, S; RINALDI, G; BADALAMENTI, G; CARRECA, I; SURMACZ, E; COLUCCI, G; BAZAN, V; RUSSO, A
FULVESTRANT AND CAPECITABINE IN ELDERLY ADVANCED BREAST CANCER PATIENTS: THE PROPOSAL FOR AN EFFECTIVE AND SAFE COMBINED TREATMENT SCHEDULE.
2007-01-01 GIUSEPPE BRONTE; FERNANDA BELLOMO; MARCO BURGIO; ANNAPAOLA CARRECA; DARIO PIAZZA; SERGIO RIZZO; SALVATORE RUSSO; CARRECA I
Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis.
2009-01-01 Russo, A; Rizzo, S; Fulfaro, F; Adamo, V; Santini, D; Vincenzi, B; Gebbia, N; Carreca, I
Impact of the new 5-HT3 receptor antagonist palonosetron (P) in chemotherapy-induced nausea and vomiting (CINV) control in elderly advanced breast cancer (EABC) patients: Comparison with the classic antiemetic agent ondansetron (O).
2007-01-01 CARRECA I; F BELLOMO; G BRONTE; M BURGIO; D PIAZZA; S RIZZO; S RUSSO; L BALDUCCI
Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring
2011-01-01 Carreca, i; Bellomo, f; Pernice, g; Antista, m; Amelio, r; Balducci, l